177Lu-DOTATOC Peptide Receptor Radionuclide Therapy in a Patient With Neuroendocrine Breast Carcinoma and Breast Invasive Ductal Carcinoma.
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000003005
Abstract: Radiolabeled somatostatin analogs for somatostatin receptor (SSTR)-targeted imaging and peptide receptor radionuclide therapy (PRRT) have demonstrated remarkable success in the management of SSTR-expressing neuroendocrine neoplasms. Primary neuroendocrine breast carcinoma is rare. Heterogeneous SSTR overexpression has… read more here.
Keywords: carcinoma; breast carcinoma; neuroendocrine breast; receptor ... See more keywords
Retrospective study of neuroendocrine breast cancer cases from a single institution in Québec.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e12588
Abstract: e12588 Background: Within numerous breast cancer types, the neuroendocrine subtype distinguishes itself from the others by its rarity. Most of the actual data comes from European and Asian retrospective studies, whom were mostly published before… read more here.
Keywords: neuroendocrine breast; study; breast cancer; breast ... See more keywords
Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum]
Sign Up to like & getrecommendations! Published in 2017 at "OncoTargets and therapy"
DOI: 10.2147/ott.s135552
Abstract: [This corrects the article on p. 397 in vol. 10, PMID: 28176908.]. read more here.
Keywords: breast carcinomas; analysis review; carcinomas retrospective; primary neuroendocrine ... See more keywords